Revvity (RVTY) Other Non-Current Assets (2010 - 2026)
Revvity's (RVTY) quarterly Other Non-Current Assets came in at $322.1 million in Q2 2026, up 7.53% YoY from $299.6 million in Q2 2025, and little changed on a QoQ basis from $323.5 million in Q4 2025.
Revvity (RVTY) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Revvity (RVTY) has 17 years of Other Non-Current Assets data on file, last reported at $322.1 million in Q2 2026.
- Quarterly Other Non-Current Assets rose 7.53% year-over-year to $322.1 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $322.1 million (up 7.53% YoY) and the FY2025 annual result came in at $323.5 million, up 12.16% from the prior year.
- Other Non-Current Assets held at $322.1 million in Q2 2026, from $323.5 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.7 billion in Q1 2023 to a low of $288.4 million in Q4 2024.
- A 5-year average of $485.0 million and a median of $321.6 million in 2025 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 434.18% in 2023, down 81.48% in 2023.
- Tracing RVTY's Other Non-Current Assets over 5 years: stood at $1.7 billion in 2022, then plunged by 79.31% to $343.0 million in 2023, then declined by 15.91% to $288.4 million in 2024, then grew by 12.16% to $323.5 million in 2025, then fell by 0.43% to $322.1 million in 2026.
- The last three Other Non-Current Assets figures came in at $322.1 million (Q2 2026), $323.5 million (Q4 2025), and $300.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 567.73 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 277.00 Mn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | 322.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 322.10 Mn |
| Dec 28, 2025 | 323.48 Mn |
| Sep 28, 2025 | 300.44 Mn |
| Jun 29, 2025 | 321.06 Mn |
| Mar 30, 2025 | 299.55 Mn |
| Dec 29, 2024 | 288.40 Mn |
| Sep 29, 2024 | 332.22 Mn |
| Jun 30, 2024 | 296.79 Mn |
| Mar 31, 2024 | 297.64 Mn |
| Dec 31, 2023 | 342.97 Mn |
| Oct 1, 2023 | 307.03 Mn |
| Jan 1, 2023 | 1.69 Bn |
| Oct 2, 2022 | 1.66 Bn |
| Jul 3, 2022 | 324.25 Mn |
| Apr 3, 2022 | 334.79 Mn |
| Jan 2, 2022 | 317.07 Mn |
| Oct 3, 2021 | 321.67 Mn |
| Jul 4, 2021 | 486.31 Mn |
| Apr 4, 2021 | 346.70 Mn |
| Jan 3, 2021 | 333.05 Mn |